Cargando…
Long-term kidney survival analyses in IgA nephropathy patients under steroids therapy: a case control study
BACKGROUND: Corticosteroids are preferred to treat patients with active IgA nephropathy (IgAN), and beneficial effects from the short-term use of corticosteroids have been confirmed. However, a large number of patients will progress to end-stage renal disease after a long time follow-up. This study...
Autores principales: | Yuan, Yanhong, Wang, Qin, Ni, Zhaohui, Che, Xiajing, Cao, Liou, Shao, Xinghua, Zhang, Minfang, Xie, Yuanyuan, Qi, Chaojun, Zhou, Wenyan, Tian, Lei, Mou, Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467637/ https://www.ncbi.nlm.nih.gov/pubmed/26048044 http://dx.doi.org/10.1186/s12967-015-0549-2 |
Ejemplares similares
-
Time-averaged albumin predicts the long-term prognosis of IgA nephropathy patients who achieved remission
por: Ni, Zhaohui, et al.
Publicado: (2014) -
Association of Relapse with Renal Outcomes under the Current Therapy Regimen for IgA Nephropathy: A Multi-Center Study
por: Yuan, Yanhong, et al.
Publicado: (2015) -
C4d as a Screening Tool and an Independent Predictor of Clinical Outcomes in Lupus Nephritis and IgA Nephropathy
por: Yang, Xiaoqian, et al.
Publicado: (2022) -
Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy
por: Min, Lulin, et al.
Publicado: (2017) -
Serum IL-18 Is Closely Associated with Renal Tubulointerstitial Injury and Predicts Renal Prognosis in IgA Nephropathy
por: Shi, Beili, et al.
Publicado: (2012)